Clinical trial of Amrutadi Guggulu in Hypothyroidism along with Thyroxine

An open labelled randomized controlled trial to evaluate efficacy of Amrutadi Guggulu as an add on effect in the management of Hypothyroidism along with Thyroxine - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101857

Enrollment

Registered

2026-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients between the ages of 19 years to 50 years with irrespective sex, cast, religions. 2) Thyroid stimulating hormone (TSH) level more than 4.25 3) Patient currently on Tab. Thyroxine 25 mcg to 100 mcg 4) Chronicity of hypothyroidism below 5 years. 5) Patients suffering from Hypothyroidism.

Exclusion criteria

Exclusion criteria: 1. Patients having any other major complicated systematic diseases like cardiac disease, diabetes mellitus. 2. Drugs (Amiodarone, Lithium) induce Hypothyroidism. 3. Pregnancy and lactating mother. 4. Hypothyroidism caused due to the administration of chemotherapy, radiotherapy and post thyroidectomy.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of the Amrutadi Guggulu as an add-on effect in reduction of the symptoms of Hypothyroidism in 45 dayTimepoint: at baseline, 2 weeks, 4 weeks and 6 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR SHRADDHA HARAJI MULEY

MAMs Sumatibhai Shah Ayurved College Hadapsar Pune

muleshraddha1351@gmail.com9373834860

Outcome results